| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/27/2009 | US20090215721 Dietary compositions and related methods of use |
| 08/27/2009 | US20090215720 Polysaccharides Compositions Comprising Fucans and Galactans and their Use to Reduce Extravasation and Inflammation |
| 08/27/2009 | US20090215718 Carbohydrate composition for flat glucose response |
| 08/27/2009 | US20090215717 Sulfated oligosaccharides |
| 08/27/2009 | US20090215716 Nitroguanosine-3' 5'-cyclic monophosphate compound and protein kinase g activating agent |
| 08/27/2009 | US20090215715 Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer |
| 08/27/2009 | US20090215714 Pyrimidines, such as cytidine, in treatments for patients with biopolar disorder |
| 08/27/2009 | US20090215713 Use of atp for the manufacture of a medicament for the prevention and treatment of oxidative stress and related conditions |
| 08/27/2009 | US20090215712 Pyrazole derivatives |
| 08/27/2009 | US20090215711 Novel compositions and methods in cancer |
| 08/27/2009 | US20090215710 Carbohydrate based toll-like receptor (tlr) antagonists |
| 08/27/2009 | US20090215709 Methylation markers for diagnosis and treatment of cancers |
| 08/27/2009 | US20090215708 Treatment of Sexual Dysfunction with Proton Pump Agonists |
| 08/27/2009 | US20090215707 Compound having cyclic structure and use thereof |
| 08/27/2009 | US20090215706 C-linked glucuronide of n-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growth |
| 08/27/2009 | US20090215705 Alpha 7 Nicotinic Receptor Selective Ligands |
| 08/27/2009 | US20090215704 Health-related liquid compositions |
| 08/27/2009 | US20090215701 Enhancement of Iron Chelation Therapy |
| 08/27/2009 | US20090215698 Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof |
| 08/27/2009 | US20090215691 NOGO Receptor Antagonists |
| 08/27/2009 | US20090215687 Compounds for Enhancing Hypoxia Inducible Factor Activity and Methods of Use |
| 08/27/2009 | US20090215685 Methods for inhibiting hair depigmentation and hair loss |
| 08/27/2009 | US20090215683 Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex |
| 08/27/2009 | US20090215681 Methods of Diagnosis and Treatment of Metabolic Disorders |
| 08/27/2009 | US20090215679 Disease-associated proteins |
| 08/27/2009 | US20090215674 Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent |
| 08/27/2009 | US20090215672 Cys-Rich, Cell Surface Glycoproteins |
| 08/27/2009 | US20090215666 Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent |
| 08/27/2009 | US20090215627 Crystal Structure of Biotin Carboxylase (Bc) Domain of Acetyl-Coenzyme a Carboxylase and Methods of Use Thereof |
| 08/27/2009 | US20090215145 Method for controlling nad(p)/nad(p)h ratio by oxidoreductase |
| 08/27/2009 | US20090215089 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 08/27/2009 | US20090215009 Medical material, artificial tooth root, and method of producing medical material |
| 08/27/2009 | US20090214683 Extracts of Sacred Water Lotus for the Treatment of Cancer |
| 08/27/2009 | US20090214682 Composition and methods for weight loss in a subject |
| 08/27/2009 | US20090214680 Weight Loss Composition |
| 08/27/2009 | US20090214679 Pest-combating compositions comprising soy methyl ester |
| 08/27/2009 | US20090214675 4-Chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof |
| 08/27/2009 | US20090214671 Personalizing Cancer Chemotherapy Based on Methylation and Germ-Line Mutational Analysis of BRCA-1 |
| 08/27/2009 | US20090214670 Rhcc peptide and uses thereof |
| 08/27/2009 | US20090214669 Combination anticancer therapy and pharmaceutical compositions therefore |
| 08/27/2009 | US20090214667 Medical technical product, method for producing the same and providing the same for surgery |
| 08/27/2009 | US20090214666 Chitin microparticles and their medical uses |
| 08/27/2009 | US20090214665 Controlled Release Muscarinic Receptor Antagonist Formulation |
| 08/27/2009 | US20090214664 Pharmaceutical Dosage Forms Comprising an Active Ingredient Combination of Nifedipine and/or Nisoldipine and an Angiotensini II Antagonist |
| 08/27/2009 | US20090214661 Process for the production of beadlets |
| 08/27/2009 | US20090214656 Itraconazole compositions with improved bioavailability |
| 08/27/2009 | US20090214654 Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle |
| 08/27/2009 | US20090214652 Soft tissue implants and anti-scarring agents |
| 08/27/2009 | US20090214651 Production of polyurethane foams |
| 08/27/2009 | US20090214650 Methods of Treating alcoholism and alcohol related disorders using combination drug therapy and swellable polymers |
| 08/27/2009 | US20090214648 Pharmaceutical formulations comprising ibuprofen and diphenhydramine |
| 08/27/2009 | US20090214646 Pharmaceutical formulations containing clopidogrel |
| 08/27/2009 | US20090214644 Tranexamic acid formulations with reduced adverse effects |
| 08/27/2009 | US20090214643 Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases |
| 08/27/2009 | US20090214642 Coated formulations for tolterodine |
| 08/27/2009 | US20090214638 Liposome encapsulated poly-iclc method to prophylactically treat an avian influenza viral infection |
| 08/27/2009 | US20090214637 Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity |
| 08/27/2009 | US20090214635 Identification of a conserved region of plasmodium falciparum msp3 targeted by biologically active antibodies |
| 08/27/2009 | US20090214634 Compositions and methods for the treatment of bladder cancer |
| 08/27/2009 | US20090214631 Process for the Preparation of Strontium Ranelate |
| 08/27/2009 | US20090214630 Compositions and Methods for the Treatment of Inflammatory Bowel Disease Utilizing NF-KappaB Decoy Polynucleotides |
| 08/27/2009 | US20090214629 Gene transfer method |
| 08/27/2009 | US20090214627 Methods of modifying insulin signaling using biliverdin reductase |
| 08/27/2009 | US20090214626 Platinum Complexes For Targeted Drug Delivery |
| 08/27/2009 | US20090214623 Anisotropic hydrogels |
| 08/27/2009 | US20090214607 Topical use of teprenone |
| 08/27/2009 | US20090214605 Hydrophilic Core Polymeric Micelles for the Delivery of Water-Soluble Compounds |
| 08/27/2009 | US20090214602 Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor |
| 08/27/2009 | US20090214601 Porous Drug Delivery Devices and Related Methods |
| 08/27/2009 | US20090214599 Proton pump inhibitor formulations, and methods of preparing and using such formulations |
| 08/27/2009 | US20090214593 Immunogen platform |
| 08/27/2009 | US20090214578 Immunostimulatory Single-Stranded Ribonucleic Acid with Phosphodiester Backbone |
| 08/27/2009 | US20090214577 Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof |
| 08/27/2009 | US20090214575 Annexin II and uses thereof |
| 08/27/2009 | US20090214573 Modulation of bne development |
| 08/27/2009 | US20090214572 Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders |
| 08/27/2009 | US20090214571 Colon cancer related gene tom34 |
| 08/27/2009 | US20090214564 Anti-ephrinb2 antibodies and methods using same |
| 08/27/2009 | US20090214563 Treatment for antiphospholipid-syndrome-related pregnancy complications |
| 08/27/2009 | US20090214562 Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection |
| 08/27/2009 | US20090214555 Proteoglycan Splice Variants as Therapeutics and Diagnostics for Amyloid Diseases |
| 08/27/2009 | US20090214554 Truncated memapsin 2 compositions and treatments |
| 08/27/2009 | US20090214552 Novel Egg Receptors for Sperm Proteins |
| 08/27/2009 | US20090214550 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 08/27/2009 | US20090214548 TGR3-Like Protein Receptor |
| 08/27/2009 | US20090214542 Novel therapeutic targets in cancer |
| 08/27/2009 | US20090214538 Use of complement inhibitors to treat ocular diseases |
| 08/27/2009 | US20090214537 Serum Resistance Factors of Gram Positive Bacteria |
| 08/27/2009 | US20090214536 CACNA1E in Cancer Diagnosis, Detection and Treatment |
| 08/27/2009 | US20090214532 ANKTM1, A Cold-Activated TRP-Like Channel Expressed in Nociceptive Neurons |
| 08/27/2009 | US20090214530 MODIFIED CpG OLIGODEOXYNUCLEOTIDE WITH IMPROVED IMMUNOREGULATORY FUNCTION |
| 08/27/2009 | US20090214529 Kinesin inhibitors |
| 08/27/2009 | US20090214524 Methods and compositions for regulating cell cycle checkpoints |
| 08/27/2009 | US20090214518 Methods and compositions for treating solid tumors and enhancing tumor vaccines |
| 08/27/2009 | US20090214516 Inhibitors of Reglll Proteins as Asthma Therapeutics |
| 08/27/2009 | US20090214511 Digestible compositions of inulin for managing blood glucose levels |
| 08/27/2009 | US20090214508 Vegf-activated fas ligands |
| 08/27/2009 | US20090214505 For treating an excess of a substrate for a hyaluronidase, such as reducing scar tissue |
| 08/27/2009 | US20090214504 Methods and Compositions for Topical Treatment of Medical Conditions Including Wounds and Inflammation |
| 08/27/2009 | US20090214501 Gel-based cosmetic and wound-healing formulation and method |